Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Aug-23 4:01 PM View:  | Kandera Reinhard Chief Financial Officer Director | Hookipa Pharma Inc. (HOOK) | 21-Aug-23 | Private Purchase | 7,000 | $0.73 | $5,075.00 | 19% 36.09K to 43.09K | |
| 17-Aug-23 4:05 PM View: | Kandera Reinhard Chief Financial Officer Director | Hookipa Pharma Inc. (HOOK) | 16-Aug-23 | Private Purchase | 8,000 | $0.71 | $5,712.00 | 28% 28.09K to 36.09K | |
| 11-Jul-23 6:21 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 11-Jul-23 | Purchase | 5,000 | $0.83 | $4,142.00 | 7% 66.95K to 71.95K | |
| 11-Jul-23 6:21 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 07-Jul-23 | Private Purchase | 5,000 | $0.81 | $4,050.00 | 8% 61.95K to 66.95K | |
| 07-Jul-23 5:06 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 05-Jul-23 | Private Purchase | 5,000 | $0.89 | $4,450.00 | 9% 56.95K to 61.95K | |
| 05-Jul-23 10:00 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 03-Jul-23 | Private Purchase | 5,000 | $0.89 | $4,455.50 | 10% 51.95K to 56.95K | |
| 03-Jul-23 4:06 PM View: | Kandera Reinhard Chief Financial Officer Director | Hookipa Pharma Inc. (HOOK) | 30-Jun-23 | Private Purchase | 12,000 | $0.88 | $10,560.00 | 75% 16.09K to 28.09K | |
| 01-Feb-22 8:48 PM View: | Kandera Reinhard Chief Financial Officer Director | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 14,056 | $3.00 | $42,168.00 | 690% 2.04K to 16.09K | |
| 01-Feb-22 8:44 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 47,824 | $3.00 | $143,472.00 | 1159% 4.13K to 51.95K | |
| 01-Feb-22 8:52 PM View: | Orlinger Klaus Executive VP, Research | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 9,188 | $3.00 | $27,564.00 | 756% 1.22K to 10.4K | |
| 01-Feb-22 8:49 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 14,933 | $3.00 | $44,799.00 | 18% 85.31K to 100.24K | |
| 01-Feb-22 8:50 PM View: | Baker Christine D. Chief Business Officer | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 13,658 | $3.00 | $40,974.00 | 546% 2.5K to 16.16K | |
| 01-Feb-22 8:50 PM View: | Necina Roman Chief Technology Officer | Hookipa Pharma Inc. (HOOK) | 01-Feb-22 | Grant | 12,892 | $3.00 | $38,676.00 | 650% 1.98K to 14.88K | |
| 12-Jan-22 10:07 AM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 21-Dec-21 | Option Exercise | 22,853 | $0.10 | $2,285.30 | 30% 77.4K to 100.26K | |
| 12-Jan-22 10:07 AM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 21-Dec-21 | Market Option Sale | 14,949 | $2.49 | $37,223.00 | (15%) 100.26K to 85.31K | |
| 23-Apr-21 4:30 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 21-Apr-21 | Market Sale | 328,620 | $11.60 | $3,812,390.00 | (9%) 3.51M to 3.18M | (6%) |
| 31-Mar-21 4:06 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 29-Mar-21 | Market Sale (Planned) | 36,829 | $13.67 | $503,570.00 | (1%) 3.54M to 3.51M | 2% |
| 31-Mar-21 6:01 AM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 26-Mar-21 | Market Sale (Planned) | 35,171 | $13.69 | $481,642.00 | (< 1%) 3.58M to 3.54M | 3% |
| 29-Mar-21 4:01 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 25-Mar-21 | Market Sale (Planned) | 28,546 | $13.12 | $374,569.00 | (< 1%) 3.61M to 3.58M | (6%) |
| 26-Mar-21 7:12 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 24-Mar-21 | Market Sale (Planned) | 52,690 | $13.70 | $721,616.00 | (1%) 3.66M to 3.61M | 1% |
| 25-Mar-21 6:13 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 23-Mar-21 | Market Sale (Planned) | 40,000 | $13.91 | $556,476.00 | (1%) 3.7M to 3.66M | 5% |
| 24-Mar-21 6:16 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 22-Mar-21 | Market Sale (Planned) | 40,534 | $14.54 | $589,263.00 | (1%) 3.74M to 3.7M | 6% |
| 23-Mar-21 4:31 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 19-Mar-21 | Market Sale (Planned) | 166,230 | $14.60 | $2,427,740.00 | (4%) 3.91M to 3.74M | 1% |
| 18-Dec-20 4:04 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 17-Dec-20 | Market Option Sale | 27,979 | $11.74 | $328,343.00 | (27%) 105.38K to 77.4K | (7%) |
| 18-Dec-20 4:04 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 17-Dec-20 | Option Exercise | 48,988 | $0.10 | $4,898.80 | 87% 56.39K to 105.38K | |
| 18-Dec-20 4:04 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 16-Dec-20 | Option Exercise | 640 | $0.10 | $64.00 | 1% 56.13K to 56.77K | |
| 18-Dec-20 4:04 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 16-Dec-20 | Market Option Sale | 380 | $11.70 | $4,446.00 | (< 1%) 56.77K to 56.39K | (7%) |
| 23-Oct-20 4:03 PM View: | Lengauer Christoph Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 4,603 | -- | -- | 100% 0 to 4.6K | |
| 23-Oct-20 4:03 PM View: | O'Neill Julie Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 4,969 | -- | -- | 100% 0 to 4.97K | |
| 23-Oct-20 4:03 PM View: | Seghezzi Graziano Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 4,708 | -- | -- | 100% 0 to 4.71K | |
| 23-Oct-20 4:02 PM View: | Kelly Michael Aaron Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 5,754 | -- | -- | 100% 0 to 5.75K | |
| 23-Oct-20 4:03 PM View: | van Deventer Sander Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 2,485 | -- | -- | 100% 0 to 2.48K | |
| 23-Oct-20 4:02 PM View: | van de Winkel Jan Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 9,153 | -- | -- | 100% 0 to 9.15K | |
| 23-Oct-20 4:03 PM View: | Kaufman David Ross Director | Hookipa Pharma Inc. (HOOK) | 21-Oct-20 | Grant | 4,577 | -- | -- | 100% 0 to 4.58K | |
| 06-Oct-20 4:01 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 02-Oct-20 | Market Sale (Planned) | 300 | $10.00 | $3,000.00 | (< 1%) 3.91M to 3.91M | (26%) |
| 17-Sep-20 4:02 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 15-Sep-20 | Market Sale (Planned) | 41,597 | $12.61 | $524,476.00 | (1%) 3.95M to 3.91M | < 1% |
| 22-Jul-20 4:03 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Market Sale (Planned) | 12,483 | $11.94 | $149,102.00 | (< 1%) 3.96M to 3.95M | (5%) |
| 22-Jul-20 4:01 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Grant | 2,736 | -- | -- | 5% 53.4K to 56.13K | |
| 22-Jul-20 4:02 PM View: | Orlinger Klaus EVP, Research | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Grant | 1,216 | -- | -- | 100% 0 to 1.22K | |
| 22-Jul-20 4:02 PM View: | Necina Roman Chief Technology Officer | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Grant | 1,984 | -- | -- | 100% 0 to 1.98K | |
| 22-Jul-20 4:01 PM View: | Aldag Jorn Chief Executive Officer Director | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Grant | 4,128 | -- | -- | 100% 0 to 4.13K | |
| 22-Jul-20 4:02 PM View: | Kandera Reinhard Chief Financial Officer Director | Hookipa Pharma Inc. (HOOK) | 20-Jul-20 | Grant | 2,036 | -- | -- | 100% 0 to 2.04K | |
| 22-Jul-20 4:03 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 29-Jun-20 | Market Sale (Planned) Duplicate | 3,280 | $11.78 | $38,627.60 | (< 1%) 3.96M to 3.96M | (7%) |
| 01-Jul-20 4:16 PM View: | Sofinnova Capital Vi Fcpr 10% Owner | Hookipa Pharma Inc. (HOOK) | 29-Jun-20 | Market Sale (Planned) | 3,280 | $11.78 | $38,627.60 | (< 1%) 3.96M to 3.96M | (7%) |
| 31-Jan-20 4:01 PM View: | Matushansky Igor Chief Medical Officer | Hookipa Pharma Inc. (HOOK) | 29-Jan-20 | Market Sale | 5,500 | $12.73 | $69,992.40 | (9%) 58.9K to 53.4K | 1% |
| 27-Jan-20 4:52 PM View: | Lilja Anders Sr. VP, Technical Development | Hookipa Pharma Inc. (HOOK) | 23-Jan-20 | Option Exercise | 11,643 | $0.10 | $1,164.30 | 100% 0 to 11.64K | |
| 27-Jan-20 4:52 PM View: | Lilja Anders Sr. VP, Technical Development | Hookipa Pharma Inc. (HOOK) | 23-Jan-20 | Market Option Sale | 11,643 | $12.59 | $146,533.00 | (100%) 11.64K to 0 | < 1% |
| 21-Jan-20 4:44 PM View: | Orlinger Klaus Sr. VP, Research | Hookipa Pharma Inc. (HOOK) | 21-Jan-20 | Option Exercise | 6,789 | $0.10 | $678.90 | 100% 0 to 6.79K | |
| 21-Jan-20 4:44 PM View: | Orlinger Klaus Sr. VP, Research | Hookipa Pharma Inc. (HOOK) | 21-Jan-20 | Market Option Sale | 6,789 | $12.02 | $81,591.60 | (100%) 6.79K to 0 | (5%) |
| 21-Jan-20 4:44 PM View: | Orlinger Klaus Sr. VP, Research | Hookipa Pharma Inc. (HOOK) | 16-Jan-20 | Option Exercise | 1,711 | $0.10 | $171.10 | 100% 0 to 1.71K |
